Clever Leaves Launches Global Direct-to-Business Sales Platform to Offer Pharmaceutical-Grade Cannabis Extracts and Products
February 20 2020 - 6:30AM
Clever Leaves, a leading multi-national operator (MNO) and licensed
producer of pharmaceutical-grade medical cannabis and hemp
extracts, announced that it has launched its direct-to-business
sales platform, Clever Leaves 360, which offers pharmaceutical
-grade cannabis extracts and finished products fit for a broad
range of industries.
The Company’s portfolio of products can be
delivered anywhere in the world where the regulatory framework
allows, and Clever Leaves 360 currently serves clients throughout
Europe, Australia, and South America. The platform offers
businesses wholesale cannabis extracts with the ability to
customize based on concentration, delivery system and size. Their
current product portfolio includes medical-grade high CBD dry
flower, CBD isolate, THC-free full spectrum CBD oil and full
spectrum extracts. In the coming months, Clever Leaves 360 will
also begin offering pharmaceutical-grade high THC extracts as well
as high THC dry flower.
“Being one of the first cannabis companies with
international exportation experience, we’ve acquired vast knowledge
of the supply chain process and the ability in our cultivation and
extraction facilities to provide pharmaceutical- grade
standards. The Clever Leaves 360 sales platform strengthens our
strategy to deliver value in every touchpoint and become a business
partner for our clients around the world, including partners in
newer industries looking to tap into the burgeoning international
medical cannabis industry,” said Kyle Detwiler, CEO of Clever
Leaves.
Clever Leaves 360 offers value through:
- Reliable Supply: control and tracking throughout the supply
chain ensures a consistent product in both quality and supply
- Competitive Pricing: vertically integrated and focused on
large-scale, cost-effective production results in one of the most
competitive business solutions in the world
- Sustainable Operations: advanced operational processes combined
with optimal environmental conditions to mitigate the environmental
impact at every stage of the value chain
- Innovation Partners: a talented multidisciplinary team to drive
innovation, experience, customization and knowledge to product
creation and supply
For more information please visit:
https://www.cleverleaves360.com/
About Clever Leaves
Northern Swan Holdings, Inc. and Eagle Canada
Holdings, Inc. d/b/a Clever Leaves recently announced a definitive
agreement to fully integrate their respective operations. Clever
Leaves, the integrated company, is a multi-national cannabis
company with a mission to operate in compliance with federal and
state laws, and with an emphasis on ecologically sustainable,
large-scale cultivation and processing as the cornerstone of
building out distribution and brands. Clever Leaves is a leading
vertically integrated producer of medical cannabis and hemp
extracts and is currently cultivating over 1.8 million square feet
of greenhouses under Good Agricultural and Collection Practices
(GACP) in Colombia. Clever Leaves’ Colombian operations obtained
its Good Manufacturing Practices (GMP) certification from INVIMA,
Colombia’s food and drug regulatory agency, after inspection of its
top-of-the-line extraction facility and is being evaluated for
certification under European Good Manufacturing Practices (EU GMP).
Clever Leaves’ first extraction facility is currently capable of
extracting 24,000 kilograms of dried flower, with expansion
underway to increase expected extraction capacity to 324,000
kilograms of dried flower per year by mid-2020. In November 2019,
Clever Leaves received authorisation from INFARMED I.P., the
Portuguese regulatory authority, to start cultivation operations in
Portugal. Based on the pre-licence received, Clever Leaves
currently has a medicinal cannabis crop in Portugal. Clever Leaves
currently has a 90 hectare farm in Portugal of which it anticipates
the first harvest and full licenses by 2020. Clever Leaves is one
of the world’s largest hemp and medical cannabis producers, with a
global footprint encompassing brands, extraction facilities,
cultivation operations and other investments across Canada,
Colombia, Germany, Portugal, and the United States, and more than
700 employees worldwide.
Press contacts: McKenna Miller KCSA
Strategic Communications +1347-487-6197
mmiller@kcsa.com
Diana Sigüenza Strategic Communication Director+573102368830
Diana.siguenza@cleverleaves.com